BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 10086647)

  • 1. Cardiovascular disease in cirrhosis--a point-prevalence study in relation to glucose tolerance.
    Marchesini G; Ronchi M; Forlani G; Bugianesi E; Bianchi G; Fabbri A; Zoli M; Melchionda N
    Am J Gastroenterol; 1999 Mar; 94(3):655-62. PubMed ID: 10086647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevalence and clinical significance of diabetes mellitus in patients with liver cirrhosis].
    Kwon SY
    Taehan Kan Hakhoe Chi; 2003 Sep; 9(3):205-11. PubMed ID: 14515038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term impact of diabetes and its comorbidities in patients undergoing isolated primary coronary artery bypass graft surgery.
    Mohammadi S; Dagenais F; Mathieu P; Kingma JG; Doyle D; Lopez S; Baillot R; Perron J; Charbonneau E; Dumont E; Metras J; Desaulniers D; Voisine P
    Circulation; 2007 Sep; 116(11 Suppl):I220-5. PubMed ID: 17846307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of non-traditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: analysis of the Third National Health and Nutrition Examination Survey (NHANES III).
    Muntner P; He J; Chen J; Fonseca V; Whelton PK
    Ann Epidemiol; 2004 Oct; 14(9):686-95. PubMed ID: 15380800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes, pre-diabetes and associated risks on Minnesota code-indicated major electrocardiogram abnormality among Chinese: a cross-sectional diabetic study in Fujian province, southeast China.
    Lin L; Chen G; Zou X; Zhao J; Zhu F; Tu M; Xu S; Lin W; Yang S; Zhang Y; Lin M; Chen N; Huang H; Liang J; Li L; Yao J
    Obes Rev; 2009 Jul; 10(4):420-30. PubMed ID: 19460110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triglyceride, albuminuria and blood pressure are the major associations of non-fatal cardiovascular disease in Chinese type 2 diabetes.
    Ko GT; Chan JC; Chow CC; Yeung VT; Chan WB; So WY; Ma RC; Ozaki R; Cockram CS
    Acta Diabetol; 2003 Jun; 40(2):80-4. PubMed ID: 12861405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2.
    de Luis DA; Fernandez N; Arranz ML; Aller R; Izaola O; Romero E
    J Diabetes Complications; 2005; 19(1):42-6. PubMed ID: 15642489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).
    Barr EL; Zimmet PZ; Welborn TA; Jolley D; Magliano DJ; Dunstan DW; Cameron AJ; Dwyer T; Taylor HR; Tonkin AM; Wong TY; McNeil J; Shaw JE
    Circulation; 2007 Jul; 116(2):151-7. PubMed ID: 17576864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of peripheral arterial obstructive disease related factors among diabetic population aged > or = 50].
    Guan H; Liu ZM; Li GW; Guo XH; Xu ZR; Zou DJ; Xing HL; Liu W; Sheng ZY; Tian HM; Zhu DL; Yu DM; Zhuang WT; Chen LL; Weng JP
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(1):23-7. PubMed ID: 17403307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of peripheral vascular disease in diabetics and impaired glucose regulation subjects: a community-based study].
    Shen Q; Jia WP; Bao YQ; Lu JX; Lu HJ; Zuo YH; Du J; Liu LH; Fang R
    Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(22):1530-3. PubMed ID: 16854278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thailand diabetes registry project: prevalence of diabetic retinopathy and associated factors in type 1 diabetes mellitus.
    Chetthakul T; Likitmaskul S; Plengvidhya N; Suwanwalaikorn S; Kosachunhanun N; Deerochanawong C; Krittiyawong S; Leelawatana R; Benjasuratwong Y; Bunnag P; Prathipanawatr T; Ngarmukos C; Mongkolsomlit S; Rawdaree P
    J Med Assoc Thai; 2006 Aug; 89 Suppl 1():S17-26. PubMed ID: 17715830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke.
    Kernan WN; Viscoli CM; Inzucchi SE; Brass LM; Bravata DM; Shulman GI; McVeety JC
    Arch Intern Med; 2005 Jan; 165(2):227-33. PubMed ID: 15668371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epidemiology of cardio-vascular complications of diabetes].
    Grimaldi A; Heurtier A
    Diabetes Metab; 1999 Jun; 25 Suppl 3():12-20. PubMed ID: 10421988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors of neuropathic pain in survivors of myocardial infarction with pre-diabetes and diabetes. The KORA Myocardial Infarction Registry.
    Ziegler D; Rathmann W; Meisinger C; Dickhaus T; Mielck A;
    Eur J Pain; 2009 Jul; 13(6):582-7. PubMed ID: 18782673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence of degenerative complications of diabetes in an outpatient population].
    Idriss-Kanoun S; Kanoun F; Hsaïri H; Machgoul M; Bahri M; Ben Khalifa F
    Tunis Med; 2002 Jul; 80(7):380-6. PubMed ID: 12611347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of Type 2 diabetes and microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial disease (SMART) study.
    Soedamah-Muthu SS; Visseren FL; Algra A; van der Graaf Y;
    Diabet Med; 2008 Jan; 25(1):51-7. PubMed ID: 18199132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes mellitus and impaired glucose tolerance in thalassaemia major: incidence, prevalence, risk factors and survival in patients followed in the Ferrara Center.
    Gamberini MR; Fortini M; De Sanctis V; Gilli G; Testa MR
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():285-91. PubMed ID: 16462713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction.
    Bartnik M; Malmberg K; Norhammar A; Tenerz A; Ohrvik J; Rydén L
    Eur Heart J; 2004 Nov; 25(22):1990-7. PubMed ID: 15541834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of intensified comprehensive cardiac rehabilitation to improve risk factor control in patients with type 2 diabetes mellitus or impaired glucose tolerance--the randomized DANish StUdy of impaired glucose metabolism in the settings of cardiac rehabilitation (DANSUK) study.
    Soja AM; Zwisler AD; Frederiksen M; Melchior T; Hommel E; Torp-Pedersen C; Madsen M
    Am Heart J; 2007 Apr; 153(4):621-8. PubMed ID: 17383302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.